Can Marijuana Cause Hallucinations and Delusions?

Marijuana can cause both hallucinations and delusions, though the risk depends heavily on how much you use, the potency of what you use, and your individual biology. THC, the plant’s main psychoactive compound, reliably produces transient psychotic symptoms in controlled experiments with healthy volunteers, and large population studies show a clear, dose-dependent link between cannabis use and real-world psychotic experiences like hearing voices or developing paranoid beliefs. The story gets more complicated once you factor in genetics, the age you start using, and the chemical profile of the product itself.

How Common Are Psychotic Experiences Among Cannabis Users

A cross-sectional study of more than 109,000 participants in the UK Biobank found a strong, dose-dependent relationship between cannabis use and four types of self-reported psychotic experiences: auditory hallucinations, visual hallucinations, persecutory delusions, and delusions of reference. Among people who had never used cannabis, about 4% reported at least one of these experiences. That figure rose to about 7% among those who had ever used cannabis, about 9% among ever-weekly users, and roughly 10% among ever-daily users. Persecutory delusions showed the strongest link, with daily users roughly two and a half times more likely to report them than people who never used cannabis.¹

These numbers do not mean that one in ten daily users is walking around psychotic. The psychotic experiences captured in a survey like this range from fleeting and mild (briefly feeling watched, hearing your name called when no one is there) to persistent and distressing. Most cannabis users never experience anything that rises to the level of a clinical psychotic episode. But the dose-response pattern is consistent and has held up across multiple study designs: the more you use, the more likely you are to have at least some psychotic-like experiences.

Why THC Potency Matters

Not all cannabis is equally risky. The concentration of THC in the product you consume is one of the strongest predictors of whether you will experience psychotic symptoms. A study comparing people experiencing their first episode of psychosis with healthy controls found that 78% of the psychosis group used high-potency cannabis, compared with just 37% of the control group. People who used high-potency products had roughly seven times the odds of psychosis compared with those who did not.² This makes biological sense: THC is the compound doing the heavy lifting when it comes to psychotic symptoms, so products with more of it deliver a larger dose of the problematic ingredient.

This point is worth underscoring because THC concentrations in commonly available cannabis products have climbed steeply over the past two decades. Concentrates, vape cartridges, and selectively bred flower strains can contain far more THC than what was typical a generation ago. The research linking chronic use of high-potency cannabinoids to increased psychosis risk is consistent across studies and extends to daily users and those who start young.³

Does CBD Protect Against THC-Induced Psychosis

You may have heard that CBD, the other major cannabinoid in the plant, counteracts THC’s psychotic effects. The evidence here is genuinely mixed. One well-designed experiment found that pre-treatment with CBD made people significantly less likely to experience clinically meaningful psychotic symptoms after receiving THC, and also reduced paranoia and protected against memory impairment.⁴ That finding supports the idea that high-THC, low-CBD products carry extra risk.

But a systematic review and meta-analysis that pooled results across multiple studies found the picture was less clear: of four studies evaluating whether CBD blunted THC-induced psychiatric symptoms, only one showed a significant reduction. A single small study with just six participants reported that CBD reduced THC-induced positive symptoms, but three larger studies failed to replicate that result.⁵ So while CBD may offer some buffer, it is not a reliable antidote. Relying on a high-CBD strain to prevent psychotic effects from a high-THC product would be getting ahead of the science.

How THC Triggers Paranoia and Perceptual Distortions

Understanding why THC causes these effects helps explain why they feel so convincing in the moment. In the brain, THC acts on CB1 receptors, which are scattered densely across regions involved in perception, memory, and emotional processing. Animal research indicates that THC increases dopamine levels in several brain areas, including the striatum and prefrontal cortex. Dopamine dysregulation in these circuits is central to how psychosis unfolds in conditions like schizophrenia, and THC appears to tap into the same pathway.

A separate line of research has looked at what THC does to brainwave patterns. Normal perception depends on synchronized neural oscillations, and THC disrupts these rhythms, particularly in the gamma and theta frequency bands. Those are the same oscillation patterns that are disturbed in schizophrenia, which may explain why THC-induced psychotic symptoms resemble the real thing so closely.

An experiment that gave intravenous THC to 121 volunteers and meticulously tracked their mental states found that THC significantly increased paranoia, anxiety, worry, depression, negative self-thoughts, and what the researchers called “anomalous experiences” (things like feeling unreal or perceiving your surroundings as strange). The increase in negative feelings and anomalous experiences fully accounted for the increase in paranoia. In other words, THC does not seem to create paranoia out of nowhere. It first makes you feel anxious and makes your perceptions feel slightly “off,” and paranoid thinking follows as your brain tries to explain those uncomfortable sensations.⁶

Who Is Most Vulnerable

Cannabis does not affect everyone equally, and genetics play a measurable role. Research has focused on a gene called AKT1, which is involved in dopamine signaling. People who carry two copies of a specific variant (the C/C genotype at rs2494732) appear to be substantially more sensitive to cannabis-related psychosis risk. In one study, cannabis users with the C/C genotype had more than twice the odds of developing a psychotic disorder compared with users carrying the T/T genotype. Among daily users, C/C carriers showed a sevenfold increase in the odds of psychosis compared with T/T carriers.⁷ A separate study found that this same genetic variation affected cognitive performance in cannabis-using patients with psychotic disorders, with C/C carriers showing worse reaction times and accuracy on attention tasks.⁸

You cannot get a consumer AKT1 test at the pharmacy, so this genetic information is not yet actionable in a practical sense. But it helps explain why two people can use the same product and have wildly different experiences: one walks away fine while the other spirals into paranoia or hears things. A family history of schizophrenia or bipolar disorder is a rough proxy for elevated genetic risk, and most clinical guidelines flag it as a reason to be especially cautious with cannabis.

Age matters too, particularly adolescence. A study that pooled data across three large cohorts found that cannabis use in early adolescence was associated with reduced cortical thickness in males who carried high polygenic risk scores for schizophrenia. This interaction was not observed in low-risk males or in females. Among high-risk males who used cannabis most frequently, cortical thinning was measurable compared with those who never used.⁹ The adolescent brain is still developing, and regular cannabis use during that window appears to interact with genetic vulnerability in ways that do not apply to the same degree in adults.

When Cannabis Psychosis Becomes a Lasting Diagnosis

Most THC-induced hallucinations and delusions are transient. They resolve as the drug clears your system, or within a few days at most. But for a meaningful minority of people who experience a cannabis-induced psychotic episode, it does not stay a one-off event. A large study following patients diagnosed with substance-induced psychosis found that about a third eventually received a diagnosis of schizophrenia or bipolar disorder. Cannabis-induced psychosis had the highest conversion rate of any substance: roughly 47% of those patients went on to develop either schizophrenia-spectrum or bipolar disorders.¹⁰

A more recent study confirmed this pattern with more granular data: the six-year cumulative transition rate from substance-induced psychosis to schizophrenia-spectrum disorder was about 28%, with men, younger individuals, and those with cannabis-induced psychosis at the highest risk. The transition to bipolar disorder was lower, around 4.5%, and was more common in women. Repeated emergency visits for substance-induced psychosis also increased the risk of transition for both sexes.¹¹

This does not mean cannabis “causes” schizophrenia in nearly half the people who have a psychotic episode on it. Some of those individuals were likely on a trajectory toward psychosis regardless, and cannabis accelerated or unmasked what was already developing. But the numbers make clear that a cannabis-induced psychotic episode is not something to shrug off. It is one of the strongest warning signs that a person may be vulnerable to a chronic psychotic illness.

How Cannabis Psychosis Looks Different From Schizophrenia

Clinicians have noted differences between cannabis-induced psychosis and the presentation of acute schizophrenia. A cross-sectional comparison found that people with cannabis-induced psychosis were more likely to be male, more likely to show expansive (elevated or euphoric) mood, and more likely to experience visual hallucinations and feelings of derealization or depersonalization. Disturbances of general awareness were also more common. By contrast, the schizophrenia group was more likely to have pre-existing schizoid personality traits, while the cannabis psychosis group was more likely to show antisocial personality traits.¹²

These differences matter for diagnosis. Visual hallucinations, for instance, are less common in classic schizophrenia but appear more frequently in cannabis psychosis. An expansive or giddy mood during a psychotic break also points toward a substance-induced origin, whereas schizophrenia tends to present with flatter or more withdrawn affect. Of course, these are patterns, not rules. The overlap between the two presentations is substantial, and distinguishing them in the emergency room can be difficult without a clear history of recent drug use.

Synthetic Cannabinoids Are a Different Animal

Products marketed as “Spice,” “K2,” or other synthetic cannabinoid brands deserve special attention because they carry a much higher psychosis risk than natural cannabis. Unlike THC, which is a partial activator of the CB1 receptor, synthetic cannabinoids tend to be full activators with higher potency and stronger binding.¹³ They also contain no CBD at all, removing even the modest protective buffer that natural cannabis might offer.¹⁴

The result is a class of drugs that can produce severe adverse effects including hallucinations, violent behavior, psychosis, suicidal ideation, tachycardia, acute kidney failure, and seizures. These effects are reported more frequently and more severely with synthetic cannabinoids than with natural cannabis, and they are particularly dangerous for younger, inexperienced users.¹⁵¹⁶ If someone arrives in an emergency department with psychotic symptoms after using what they thought was a cannabis product but turns out to be synthetic, clinicians expect a rougher course.

What Happens When Someone Shows Up at the Emergency Room

Acute cannabis psychosis usually resolves with supportive care rather than aggressive medical intervention. The standard approach is to maintain safety, keep the person in a calm environment, and wait for the drug to clear. A case report documenting emergency management found that a patient’s psychosis, along with some physical complications, resolved over two days with minimal intervention and supportive treatment.¹⁷ Antipsychotic medications are sometimes used for severe agitation but are not always necessary.

The bigger challenge for emergency clinicians is figuring out what they are dealing with. Is this a transient intoxication that will clear in hours? A substance-induced psychotic disorder that may last days or weeks? Or the first break of a primary psychotic illness that cannabis unmasked? That distinction usually cannot be made in the ER. It requires follow-up, observation, and sometimes weeks of abstinence before a clearer picture emerges.

Sleep Disruption as a Hidden Amplifier

One underappreciated factor linking cannabis to psychotic experiences is sleep. A longitudinal study found that cannabis use predicted worsening sleep quality, and that worsened sleep in turn predicted increased psychosis-like experiences over the following years. The indirect effect was statistically significant: cannabis use affected psychotic-like experiences partly through its impact on sleep.¹⁸ Sleep deprivation alone is well known to produce perceptual distortions and paranoid thinking in otherwise healthy people, so it makes sense that cannabis could amplify psychosis vulnerability partly by degrading sleep quality over time.

This finding also offers a practical handle. If you use cannabis and notice your sleep is deteriorating, that may be more than an inconvenience. Disrupted sleep could be compounding whatever direct neurochemical risk THC poses.

Lingering Perceptual Changes After Cannabis Use

A small number of cannabis users report ongoing perceptual disturbances that persist long after the drug has left their system. This phenomenon resembles hallucinogen persisting perception disorder (HPPD), a condition more commonly associated with substances like LSD. A review of the literature identified seven reported cases where cannabis use was associated with the development of HPPD-like perceptual distortions.¹⁹ These can include visual snow, trailing images, halos around objects, and other persistent visual anomalies.

Seven cases in the published literature is a tiny number, and this outcome is clearly rare. But it is worth knowing about because people who experience it often assume something is seriously wrong with their brain. Awareness that cannabis can, in unusual cases, leave a lasting perceptual imprint may save someone an anxious spiral through emergency imaging and specialist referrals. The condition is poorly understood, and treatment options remain limited, though symptoms sometimes improve with abstinence and time.